Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study. - Test2 - elhamkhani - TriplyDB

Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.

Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.

http://www.wikidata.org/entity/Q34366183

about

Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options Using drug sales data to evaluate the epidemiology of cardiometabolic risk factors and their inequality: an ecological study on atorvastatin and total cholesterol in Iran.Relationship between Statin Utilization and Socioeconomic Deprivation in Hungary.Statin prescribing according to gender, age and indication: what about the benefit-risk balance?Adherence to preventive statin therapy according to socioeconomic position.Future cost-effectiveness and equity of the NHS Health Check cardiovascular disease prevention programme: Microsimulation modelling using data from Liverpool, UK.

P2860

Q24658434-976470D6-6929-40C8-BA4A-8936E0AC8E5F Q31038699-3131DE87-264E-4C2F-9CA3-EBC732046A6C Q36724472-191BB3D9-E50C-4CCF-B3EC-AAA37C2C96E4 Q40455288-EC23AE56-9ACF-4D76-935E-25C003D0508B Q44003644-C2F276C1-40CF-47C3-BFF2-A1FDF7CB1549 Q54985794-D747F495-91EA-4722-8891-578FB1BD14B6

P2860

Is the high-risk strategy to prevent cardiovascular disease equitable? A pharmacoepidemiological cohort study.

http://www.wikidata.org/entity/Q34366183

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Is the high-risk strategy to p ...... oepidemiological cohort study.

@ast

Is the high-risk strategy to p ...... oepidemiological cohort study.

@en

Is the high-risk strategy to p ...... oepidemiological cohort study.

@nl

type

label

Is the high-risk strategy to p ...... oepidemiological cohort study.

@ast

Is the high-risk strategy to p ...... oepidemiological cohort study.

@en

Is the high-risk strategy to p ...... oepidemiological cohort study.

@nl

prefLabel

Is the high-risk strategy to p ...... oepidemiological cohort study.

@ast

Is the high-risk strategy to p ...... oepidemiological cohort study.

@en

Is the high-risk strategy to p ...... oepidemiological cohort study.

@nl

P1433

Q34366183-03E21898-A2C4-4F29-9902-730162AC84E8

P1476

Q34366183-F0A7811A-084E-4162-8C9D-90B503EDFF71

P2093

Q34366183-2E12ACC4-2B25-414A-8A18-6F9CAADE4B92

Q34366183-7C346534-E74E-46C8-8338-932F00DAEEB3

P2860

Q34366183-0097C779-3A31-4A93-B47A-9D4A5FF37548

Q34366183-11E6D798-527B-4A93-A1C0-B3F0BBEF248D

Q34366183-1598C875-1A0D-4D83-80CB-18A177211520

Q34366183-1A1F4EE6-5CF8-4BF9-8926-AE08E253431A

Q34366183-226C08B2-AF7E-443E-8EE6-62BC3A5E520C

Q34366183-229E0CFA-0BEA-401E-8118-AC3BECDD8094

Q34366183-26CC0B78-DDAC-4BCF-B4A7-7F59F7FE61C3

Q34366183-29D66E46-E398-4035-BAB2-E462BB4D7E78

Q34366183-2B53FB9D-3513-430A-910A-0663BA2342D5

Q34366183-3A513825-E699-4208-BD09-0FE2E717B76A

P2888

Q34366183-DE885240-31FF-48E2-88FD-1B31DBD1D285

P304

Q34366183-6EC00CC2-4297-4BC9-B766-6E990E25A168

P31

Q34366183-5D97B886-7DB7-499B-83F9-C717F713444A

P356

Q34366183-5A53D543-4015-4D15-BB08-507047E60F8E

P407

Q34366183-094B3BA5-3882-41D5-8E9F-8A13DD8688A2

P478

Q34366183-8F714241-83F5-462A-A9C6-FF44F91C18BC

P50

Q34366183-7408E28C-9AC2-4CB9-9705-3B31DB9079D8

Q34366183-883D004F-63D2-4236-971F-27038672177B

Q34366183-E293ECE9-FF5C-4265-B81D-FF10359A4213

P577

Q34366183-83345091-6B19-4CD6-A255-FD300B972150

P5875

Q34366183-51D6E0BF-E549-468D-94AA-86CF459287CE

P6179

Q34366183-AF69955F-A353-4219-A202-CF373D5201FE

P698

Q34366183-FDDF1DC9-A668-4D31-98F2-2E7EF4FF4438

P921

Q34366183-829AB1AB-2A09-4822-84E4-23C9945F4D49

P932

Q34366183-2BE7318C-4032-4812-BE76-DF4DC19006A6

P356

1471-2458-12-610

P1433

BMC Public Health

P1476

Is the high-risk strategy to p ...... oepidemiological cohort study.

@en

P2093

Allan Krasnik

http://www.w3.org/2001/XMLSchema#string

Morten Andersen

http://www.w3.org/2001/XMLSchema#string

P2860

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism

Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease

Regional variation in the prescribing for diabetes and use of secondary preventative therapies in Ireland

How equitable are GP practice prescribing rates for statins?: an ecological study in four primary care trusts in North West England

Health inequalities among British civil servants: the Whitehall II study

Nonparametric estimates of standard error: The jackknife, the bootstrap and other methods

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

Closing the gap in a generation: health equity through action on the social determinants of health

A cross-validation of risk-scores for coronary heart disease mortality based on data from the Glostrup Population Studies and Framingham Heart Study.

The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry.

P2888

1471-2458-12-610

P304

610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2458-12-610

http://www.w3.org/2001/XMLSchema#string

P407

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Finn Diderichsen

Helle Wallach-Kildemoes

P577

2012-08-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230618445

http://www.w3.org/2001/XMLSchema#string

P6179

1038390649

http://www.w3.org/2001/XMLSchema#string

P698

22863326

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease

P932

3444315

http://www.w3.org/2001/XMLSchema#string